Safety Profiles of the Angiotensin-Converting Enzyme Inhibitors
- 1 January 1988
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 35 (5), 89-97
- https://doi.org/10.2165/00003495-198800355-00016
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- SULINDAC AND COUGH INDUCED BY CONVERTING ENZYME INHIBITORSThe Lancet, 1987
- Side Effects and Metabolic Effects of Converting-Enzyme InhibitorsClinical and Experimental Hypertension. Part A: Theory and Practice, 1987
- The Effects of Antihypertensive Therapy on the Quality of LifeNew England Journal of Medicine, 1986
- EnalaprilDrugs, 1986
- Enalapril in Hypertension and Congestive Heart FailureDrugs, 1985
- Drug-induced skin diseaseJournal of Allergy and Clinical Immunology, 1984
- Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Veterans Administration Cooperative Study Group on Antihypertensive AgentsArchives of Internal Medicine, 1984
- Captopril-Induced Functional Renal Insufficiency in Patients with Bilateral Renal-Artery Stenoses or Renal-Artery Stenosis in a Solitary KidneyNew England Journal of Medicine, 1983
- Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertensionThe American Journal of Cardiology, 1982
- Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.BMJ, 1981